CRP and nephrolithiasis: Additionally, no statistically significant difference was observed between the pyrin concentration (pg/mL) in FMF patients with high and normal markers: SAA (372.86 ± 19.63 vs. 387.82 ± 8.5, p = 0.48); ESR (372.83 ± 12.28 vs. 394.25 ± 8.5, p = 0.21); CRP (393.0 ± 15.36 vs. 380.59 ± 70.7, p = 0.49); H-pylori (376.33 ± 75.0 vs. 385.95 ± 76.0, p = 0.70); anemia (388.16 ± 69.0 vs. 381.18 ± 66.8, p = 0.68); vitamin D (389.8 ± 12.86 vs. 381.55 ± 70.7, p = 0.63); and renal calculi (388.75 ± 88.4 vs. 383.58 ± 61.3, p = 0.80).